Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Janus Henderson AAA CLO ETF
JAAA
$29.1B
| $59.8M | 0.03% |
1,178,810
+403,077
| +52% | +$20.4M |
|
352
Piper Sandler
PIPR
$4.99B
| $59.6M | 0.03% |
1,202,076
-58,456
| -5% | -$2.67M |
|
353
Jabil
JBL
$30.1B
| $59.5M | 0.03% |
444,736
+20,437
| +5% | +$2.74M |
|
354
Silgan Holdings
SLGN
$4.51B
| $59.5M | 0.03% |
1,224,502
+598,472
| +96% | +$26.6M |
|
|
CRGX
355
DELISTED
CARGO Therapeutics
CRGX
| $59.3M | 0.03% |
2,659,580
-43,151
| -2% | -$1.03M |
|
|
WIRE
356
DELISTED
Encore Wire Corp
WIRE
| $58.8M | 0.03% |
223,605
-15,079
| -6% | -$3.42M |
|
|
FISV
357
Fiserv Inc
FISV
$29.7B
| $58.3M | 0.03% |
365,059
-3,097
| -0.8% | -$451K |
|
358
Entergy
ETR
$50.3B
| $57.5M | 0.03% |
1,088,878
-23,662
| -2% | -$1.2M |
|
359
Atlas Energy Solutions
AESI
$1.27B
| $57.4M | 0.03% |
2,537,215
+537,927
| +27% | +$10M |
|
360
HDFC Bank
HDB
$123B
| $57.3M | 0.03% |
2,047,828
-310,560
| -13% | -$8.81M |
|
361
Neogen
NEOG
$2.05B
| $57.3M | 0.03% |
3,628,801
+46,855
| +1% | +$784K |
|
362
Brown-Forman Class B
BF.B
$13.5B
| $57.2M | 0.03% |
1,107,562
-148,615
| -12% | -$8.28M |
|
363
PepsiCo
PEP
$196B
| $57.1M | 0.03% |
326,452
-15,372
| -4% | -$2.59M |
|
364
Penumbra
PEN
$12.6B
| $56.9M | 0.03% |
254,802
-2,523
| -1% | -$624K |
|
365
Vanguard FTSE Europe ETF
VGK
$30.1B
| $56.4M | 0.03% |
837,240
+33,505
| +4% | +$2.17M |
|
366
Impinj
PI
$4.24B
| $56.4M | 0.03% |
439,562
+2,681
| +0.6% | +$281K |
|
|
EXE
367
Expand Energy Corp
EXE
$21.4B
| $56.4M | 0.03% |
634,619
-8,562
| -1% | -$687K |
|
368
Royalty Pharma
RPRX
$26.2B
| $56.3M | 0.03% |
1,852,660
-47,954
| -3% | -$1.41M |
|
369
Cytokinetics
CYTK
$10.6B
| $55.9M | 0.03% |
797,372
-1,771,033
| -69% | -$137M |
|
370
Grocery Outlet
GO
$904M
| $55.7M | 0.03% |
1,936,436
+40,055
| +2% | +$1.06M |
|
371
Ameris Bancorp
ABCB
$5.89B
| $55.7M | 0.03% |
1,151,364
-102,356
| -8% | -$4.96M |
|
372
Kimco Realty
KIM
$17.5B
| $55.5M | 0.03% |
2,828,917
+2,754,695
| +3,711% | +$54.8M |
|
373
Brady Corp
BRC
$4.46B
| $55.4M | 0.03% |
934,883
-343,908
| -27% | -$20.5M |
|
374
Toll Brothers
TOL
$14B
| $55.3M | 0.03% |
427,287
-25,919
| -6% | -$2.82M |
|
|
CSW
375
CSW Industrials
CSW
$4.44B
| $55.3M | 0.03% |
235,615
-51,459
| -18% | -$11.5M |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.